This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...